Nanollose
- Short interest
- <0.01%
- 0.00 pp 30d
- as of 16 Nov 2026
- Reported shorts
- 1.2K
- Shares on issue
- 409.827M
Nanollose (ASX:NC6) had <0.01% of shares reported as short positions as of 16 Nov 2026, representing 1,214 shares. Nanollose operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Nanollose is an Australian biotechnology company focused on developing sustainable materials, particularly Nullarbor fibre, a tree-free rayon alternative made from microbial cellulose. Their technology aims to transform liquid waste into rayon fibre for clothing, minimizing environmental impact and offering a scalable solution for the textile industry. The company is positioned to capitalize on the growing demand for eco-friendly and sustainable textile options.
Company profile →Nanollose (ASX:NC6) has <0.01% of its shares on issue reported as short positions as of 16 Nov 2026, or about 1,214 shares. Over the past 30 days that figure has been broadly flat, and over 90 days it has been broadly flat. NC6 is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 47, 2026.
Who holds NC6, as its notices state it
7 holders, 7 interests counted once, disclose 66.79% between them; largest: nd> WACC Pty Ltd <Flagship Fu Fiftyone Capital Pty Ltd 18.35% as at (7 mo), Fund WACC Pty Ltd ATF Flagship Fiftyone Capital Pty Ltd 13.84% as at (10 mo), Fund WACC Pty Ltd ATF Flagship 8.21% as at (17 mo)
Notices read to · what the notices disclose, not a share of the company · Not financial advice · Report an errorFull register →
In the year to 30 Jun 2026, Nanollose (ASX:NC6) recorded revenue of A$3.5K and a net loss after tax of A$2.4M. A year earlier it recorded revenue of A$11.9K and a net loss after tax of A$1.4M. Year-on-year growth: revenue −70.4% (FY). Net margin −67,628.0%, return on equity −300.3% (FY). Figures are in AUD, the company's reporting currency; source: ASX (Markit) and Yahoo Finance, as at 13 Nov 2026.
Full statements, ratios and filings are on the Financials tab. Not financial advice.
asx · 16 Nov 2026
kalkine · 16 Nov 2026
asx · 29 Oct 2026
website
Other shorted stocks in this sector
Be the first to discuss NC6
Start a research thread or post the first pulse update